Bonk (NASDAQ:BNKK) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded shares of Bonk (NASDAQ:BNKK) from a sell rating to a hold rating in a report issued on Saturday.

Separately, Weiss Ratings lowered Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, April 29th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the company has a consensus rating of “Sell”.

Bonk Trading Down 1.8%

BNKK opened at $2.14 on Friday. The stock has a market capitalization of $17.12 million, a price-to-earnings ratio of -0.28 and a beta of 1.97. Bonk has a 12 month low of $1.90 and a 12 month high of $46.90. The stock has a 50-day moving average of $2.63.

Bonk (NASDAQ:BNKK) last released its quarterly earnings results on Wednesday, May 13th. The company reported ($0.23) EPS for the quarter. The company had revenue of $0.79 million during the quarter. Bonk had a negative return on equity of 148.62% and a negative net margin of 838.37%.

Insider Activity

In other Bonk news, Director Mitchell Austin Rudy bought 31,055 shares of the company’s stock in a transaction on Thursday, April 9th. The stock was acquired at an average price of $2.82 per share, for a total transaction of $87,575.10. Following the completion of the transaction, the director directly owned 44,198 shares of the company’s stock, valued at approximately $124,638.36. This represents a 236.29% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 51.60% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of BNKK. State Street Corp purchased a new position in shares of Bonk during the fourth quarter valued at approximately $33,000. Steward Partners Investment Advisory LLC purchased a new position in shares of Bonk during the fourth quarter valued at approximately $37,000. Jane Street Group LLC purchased a new position in shares of Bonk during the fourth quarter valued at approximately $96,000. Finally, Geode Capital Management LLC purchased a new position in shares of Bonk during the fourth quarter valued at approximately $128,000. Hedge funds and other institutional investors own 12.55% of the company’s stock.

About Bonk

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.